Adagene Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$6.15 | $223.86 M | -2.51 | 58 | $0 |
ANAB
AnaptysBio, Inc. |
$13.74 | $640.07 M | -3.82 | 117 | $17.16 M |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
AVTE
Aerovate Therapeutics, Inc. |
$2.63 | $597.48 M | -6.84 | 51 | $0 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $258.33 M | -17.08 | 9 | $0 |
JANX
Janux Therapeutics, Inc. |
$55.17 | $2.29 B | -36.8 | 76 | $8.08 M |
MLYS
Mineralys Therapeutics, Inc. |
$12.87 | $652.38 M | -6.03 | 28 | $0 |
MOLN
Molecular Partners AG |
$5.31 | $135.05 M | -2.03 | 167 | $7.04 M |
PMVP
PMV Pharmaceuticals, Inc. |
$1.51 | $85.40 M | -1.26 | 63 | $0 |
RZLT
Rezolute, Inc. |
$5.01 | $229.57 M | -5.02 | 59 | $0 |